DOWNLOAD REQUEST – FCF LIFE SCIENCES RESEARCH SERIES
FCF Life Sciences engages in research on recent financing trends in the Life Sciences sector, i.e. biotechnology, pharma and med-tech. FCF primarily focuses on the latest activities in the equity capital markets: Venture Capital, Initial Public Offerings (IPO) and Equity Valuations.
The findings are regularly published in:
NEWS & PRESS

FCF Life Sciences Venture Capital Report – 2020 published
FCF Fox Corporate Finance GmbH is delighted to publish the new “FCF Life Sciences Venture Capital Report – 2020”. The Venture Capital Report, part of FCF Life Sciences Research Series, is the most detailed and

FCF Life Sciences Venture Capital Monitor – Europe 01/2021 published
FCF Fox Corporate Finance GmbH is delighted to publish the new “FCF Life Sciences Venture Capital Monitor – Europe 01/2021”. The Monitor is a monthly published overview of venture capital trends in the European Life

FCF Biotech Venture Capital Monitor – USA 01/2021 published
FCF Fox Corporate Finance GmbH is delighted to publish the new “FCF Biotech Venture Capital Monitor – USA 01/2021”. The Monitor is a monthly published overview of venture capital trends in the US-Biotech sector. As

FCF Life Sciences Venture Capital Monitor – Europe 12/2020 published
FCF Fox Corporate Finance GmbH is delighted to publish the new “FCF Life Sciences Venture Capital Monitor – Europe 12/2020”. The Monitor is a monthly published overview of venture capital trends in the European Life

Dr. Joachim Greuel is the latest expert to join the Life Sciences Advisory Board at FCF Fox Corporate Finance GmbH
Complementing the leading industry experts already advising the Munich-based corporate financing specialist, Dr. Joachim Greuel joins FCF’s Life Sciences Advisory Board. Munich, January 18, 2021 FCF Fox Corporate Finance GmbH (“FCF”) welcomes yet another renowned